Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
A gang of men have been jailed for more than 140 years for raping the same Keighley schoolgirl when she was aged 14 and 15.
A mum from Bradford has amazed doctors by giving birth to her third set of non identical twins.
Two-year-old Sophie spent six days on life-support after battery acid burnt a hole in her lung, but has since made a full recovery.